Alkermes ALKS
NASDAQ ALKS
$46.17 +0.27 (+0.59%)
At close: Nov 9, 2026 · 4:00 PM EST

Alkermes (ALKS) Interest & Investment Income (2010 - 2026)

Updated

Alkermes (ALKS) reported Interest & Investment Income of $6.49 million for Q3 2026, down 45.7% from $11.94 million a year earlier but up 21.4% from the prior quarter.

Analysis

Alkermes (ALKS) Interest & Investment Income (2010 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Alkermes' Interest & Investment Income came in at $32.5 million, down 27.1% year-over-year; for FY2025, it came in at $45.3 million, up 6.7% from FY2024.

  • Interest & Investment Income has increased for four consecutive years, with a five-year compound annual growth rate of 45.4% (FY2020 to FY2025).
  • By year, Interest & Investment Income came in at $42.45 million in FY2024 (+37.6%), $30.85 million in FY2023 (+304.4%), $7.63 million in FY2022 (+216.8%) and $2.41 million in FY2021 (-65.4%).
  • Five-year quarterly Interest & Investment Income spans a low of $453,000 in Q4 2021 and a high of $12.13 million in Q4 2025.
  • Year over year, Interest & Investment Income has now declined in each of the last three quarters, with an average decline of 8.7% over the last eight quarters.
  • The high point for year-over-year Interest & Investment Income in five years was Q1 2023 (growth of 766.7%); the low point was Q4 2021 (a decline of 56.3%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $5.34 million (Q2 2026), $8.54 million (Q1 2026) and $12.13 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 186.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Alkermes 7.77 Bn 5.26 Bn 385.91 Mn 6.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 6.49 Mn
Jun 30, 2026 5.34 Mn
Mar 31, 2026 8.54 Mn
Dec 31, 2025 12.13 Mn
Sep 30, 2025 11.94 Mn
Jun 30, 2025 11.09 Mn
Mar 31, 2025 10.14 Mn
Dec 31, 2024 11.40 Mn
Sep 30, 2024 10.92 Mn
Jun 30, 2024 10.74 Mn
Mar 31, 2024 9.40 Mn
Dec 31, 2023 9.75 Mn
Sep 30, 2023 9.37 Mn
Jun 30, 2023 6.77 Mn
Mar 31, 2023 4.97 Mn
Dec 31, 2022 3.92 Mn
Sep 30, 2022 2.24 Mn
Jun 30, 2022 896,000.00
Mar 31, 2022 573,000.00
Dec 31, 2021 453,000.00
API Access

Alkermes Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ALKS&period=max&api_key=YOUR_API_KEY